Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 31, 2021

Primary Completion Date

December 10, 2024

Study Completion Date

June 9, 2025

Conditions
Out-Of-Hospital Cardiac ArrestPostcardiac Arrest Syndrome
Interventions
DRUG

The combined supplement of Ascorbic acid, Thiamine, and Cortisol

"The combined administration of 3 drugs will be mixed in a 50 mL 0.9% saline bag respectively and administered through intravenous infusion over 60 min every 12 h for 3 days.~1. Ascorbic acid (Ascorbic acid Inj \[500mg\]®): 50 mg/kg, maximum single dose 3 g, daily dose 6 g~2. Thiamine (Thiamine hcl inj \[50mg\]®): 200 mg~3. Cortisol (Cortisolu inj \[100mg\]®): 100mg (The main exposure was corticosteroid therapy, defined as the use of systemic corticosteroids. But if unavailable, it could be converted to hydrocortisone-equivalent doses (methylprednisolone 1:5, dexamethasone 1:25, prednisolone 1:4).)"

DRUG

Placebo

An identical volume of 0.9% saline (150mL) administered through intravenous infusion over 60 min every 12 h for 3 days.

Trial Locations (1)

05505

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Seoul St. Mary's Hospital

OTHER

collaborator

Wonju Severance Christian Hospital

OTHER

collaborator

Samsung Changwon Hospital

OTHER

collaborator

Samsung Medical Center

OTHER

collaborator

Chung-Ang University

OTHER

collaborator

Hanyang University

OTHER

collaborator

Ewha Womans University

OTHER

collaborator

Hanil General Hospital

UNKNOWN

lead

Asan Medical Center

OTHER